Preliminary experiments point out conolidine could inhibit particular ion channels, lowering neuronal excitability and limiting discomfort alerts. This system is especially suitable in neuropathic ache, where by abnormal signaling leads to persistent distress. Furthermore, conolidine seems to influence G protein-coupled receptor (GPCR) pathways int